InvestorsHub Logo

Gladys Thong

11/25/19 2:34 AM

#61747 RE: JohnCM #61745

CVSciences should fear Q4

CV Sciences faces two significant headwinds that Charlotte's Web does not:


1. Lack of brand differentiation -
Every "<whatever>CBD" upstart product looks and sounds
a lot like "PlusCBD"
2. "CBD" incorporated in the brandname -
which prompts some retailers who sell in states that
restrict CBD in ingestibles to avoid those products.
Those states are approximately 1/3 of USA population.
For example, The Vitamin Shoppe


But, regarding 2., I believe it's more than just the wording, now and IN THE FUTURE.

"CBD" has been identified by the FDA as a drug. That is NOT SO for "Hemp Extract" with more than 80 naturally occurring phytocannabinoids, including CBD, and other beneficial plant compounds.

So Charlotte's patented hemp cultivar with naturally occurring high levels of CBD is very important.